These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study. Yoon JH; Kim M; Moon SY; Yong SW; Hong JM J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880 [TBL] [Abstract][Full Text] [Related]
5. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study. Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of mild cognitive impairment subtypes in patients attending a memory outpatient clinic--comparison of two modes of mild cognitive impairment classification. Results of the Vienna Conversion to Dementia Study. Pusswald G; Moser D; Gleiss A; Janzek-Hawlat S; Auff E; Dal-Bianco P; Lehrner J Alzheimers Dement; 2013 Jul; 9(4):366-76. PubMed ID: 23164551 [TBL] [Abstract][Full Text] [Related]
7. Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain. Cammisuli DM; Sportiello MT Psychiatr Danub; 2017 Dec; 29(4):437-445. PubMed ID: 29197200 [TBL] [Abstract][Full Text] [Related]
8. Neuropsychological predictors of conversion to probable Alzheimer disease in elderly with mild cognitive impairment. García-Herranz S; Díaz-Mardomingo MC; Peraita H J Neuropsychol; 2016 Sep; 10(2):239-55. PubMed ID: 25809316 [TBL] [Abstract][Full Text] [Related]
9. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease. Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836 [TBL] [Abstract][Full Text] [Related]
10. Can mild cognitive impairment be accurately diagnosed in english speakers from linguistic minorities? Results from the Sydney Memory and Ageing study. Low LF; Harrison F; Kochan NA; Draper B; Slavin MJ; Reppermund S; Sachdev PS; Brodaty H Am J Geriatr Psychiatry; 2012 Oct; 20(10):866-77. PubMed ID: 22261551 [TBL] [Abstract][Full Text] [Related]
11. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia. Park JH; Park H; Sohn SW; Kim S; Park KW Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252 [TBL] [Abstract][Full Text] [Related]
13. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study. Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory. Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal Trajectories of Informant-Reported Daily Functioning in Empirically Defined Subtypes of Mild Cognitive Impairment. Thomas KR; Edmonds EC; Delano-Wood L; Bondi MW J Int Neuropsychol Soc; 2017 Jul; 23(6):521-527. PubMed ID: 28487004 [TBL] [Abstract][Full Text] [Related]
16. Altered Executive Function in Pre-Mild Cognitive Impairment. Seo EH; Kim H; Lee KH; Choo IH J Alzheimers Dis; 2016 Oct; 54(3):933-940. PubMed ID: 27567814 [TBL] [Abstract][Full Text] [Related]
17. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests. Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860 [TBL] [Abstract][Full Text] [Related]
18. Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study. Di Carlo A; Baldereschi M; Lamassa M; Bovis F; Inzitari M; Solfrizzi V; Panza F; Galluzzo L; Scafato E; Inzitari D; J Alzheimers Dis; 2016 May; 53(2):505-15. PubMed ID: 27163817 [TBL] [Abstract][Full Text] [Related]
19. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia. Galtier I; Nieto A; Lorenzo JN; Barroso J J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176 [TBL] [Abstract][Full Text] [Related]
20. Functional impairment as a defining feature of: amnestic MCI cognitive, emotional, and demographic correlates. Bombin I; Santiago-Ramajo S; Garolera M; Vega-González EM; Cerulla N; Caracuel A; Cifuentes A; Bascarán MT; Bobes J Int Psychogeriatr; 2012 Sep; 24(9):1494-504. PubMed ID: 22717386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]